These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3110949)

  • 1. Companies vie over new heart drug.
    Sun M
    Science; 1987 Jul; 237(4811):120-2. PubMed ID: 3110949
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems over TPA patent for Genentech in Japan.
    Swinbanks D
    Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683
    [No Abstract]   [Full Text] [Related]  

  • 3. TPA patent battle rages in United Kingdom.
    Johnston K
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108671
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology patents. Genentech wins round two.
    Gershon D
    Nature; 1990 Apr; 344(6268):692. PubMed ID: 2109830
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA puts new heart drug on hold.
    Sun M
    Science; 1987 Jul; 237(4810):16-8. PubMed ID: 3110948
    [No Abstract]   [Full Text] [Related]  

  • 6. Genentech falls at the last fence in race to market heart drug.
    Anderson A
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108670
    [No Abstract]   [Full Text] [Related]  

  • 7. Genentech gets patent protection for tissue plasminogen activator.
    Ezzell C
    Nature; 1988 Jun; 333(6176):790. PubMed ID: 3133565
    [No Abstract]   [Full Text] [Related]  

  • 8. New clot busters threaten Genentech's tPA.
    Davidson S
    Nat Biotechnol; 1997 May; 15(5):405. PubMed ID: 9131608
    [No Abstract]   [Full Text] [Related]  

  • 9. Ruling on heart drug may boost research.
    Sun M
    Science; 1987 Jul; 237(4812):244. PubMed ID: 3110951
    [No Abstract]   [Full Text] [Related]  

  • 10. Boehringer Mannheim's new clot buster.
    Nat Biotechnol; 1997 Feb; 15(2):114. PubMed ID: 9035121
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-examination ends in TPA patent case.
    Newmark P
    Nature; 1987 Jun 25-Jul 1; 327(6124):650. PubMed ID: 3110622
    [No Abstract]   [Full Text] [Related]  

  • 12. New battle over TPA.
    Ezzell C
    Nature; 1989 Aug; 340(6233):418. PubMed ID: 2502715
    [No Abstract]   [Full Text] [Related]  

  • 13. Betting on biogenerics.
    Dove A
    Nat Biotechnol; 2001 Feb; 19(2):117-20. PubMed ID: 11175723
    [No Abstract]   [Full Text] [Related]  

  • 14. New data clinch heart drug approval.
    Sun M
    Science; 1987 Nov; 238(4830):1031. PubMed ID: 3120310
    [No Abstract]   [Full Text] [Related]  

  • 15. Growing strong. Biotechnology's new wave hopes that being first will pay off.
    Erickson D
    Sci Am; 1992 Jan; 266(1):134, 136. PubMed ID: 1734508
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotechnology. All systems go in Britain.
    Newmark P
    Nature; 1986 Mar 13-19; 320(6058):100. PubMed ID: 2419766
    [No Abstract]   [Full Text] [Related]  

  • 17. Claims on tissue plasminogen activator.
    Crespi RS
    Nature; 1989 Jan; 337(6205):317-8. PubMed ID: 2492089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomedical patents. Broad patent faces narrow odds in court battle.
    Garber K
    Science; 2006 Mar; 311(5769):1855-7. PubMed ID: 16574836
    [No Abstract]   [Full Text] [Related]  

  • 19. Wellcome versus Genentech result.
    Johnston K
    Nature; 1987 Jul 16-22; 328(6127):189. PubMed ID: 3110626
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on US geographic distribution of recombinant tissue plasminogen activator use by hospitals for acute ischemic stroke.
    Albright K; Martin-Schild S; Morales M; Grotta J
    Stroke; 2010 Apr; 41(4):e189; author reply e190. PubMed ID: 20185785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.